SLC2A4 and Insulin resistance: Furthermore, it mitigated insulin resistance by upregulating the expression of insulin‐sensitive factors, such as GLUT4 and IRS2, while concurrently downregulating insulin resistance factors, including PTP1B and SOCS3 (Figure 3F).